---All---
  • ---All---
  • Accession
  • Catalog #

UBE2M Antibody (C-term) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP1068b 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

UBE2M Antibody (C-term) Blocking Peptide - Product info

Primary AccessionP61081
Other AccessionNP_003960
Clone Names2112204
Calculated MW20900 Da

UBE2M Antibody (C-term) Blocking Peptide - Additional info

Gene ID 9040
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP1068b was selected from the C-term region of human UBE2M. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

UBE2M Antibody (C-term) Blocking Peptide - Protein Information

Name UBE2M
Synonyms UBC12
Function
Accepts the ubiquitin-like protein NEDD8 from the UBA3- NAE1 E1 complex and catalyzes its covalent attachment to other proteins. The specific interaction with the E3 ubiquitin ligase RBX1, but not RBX2, suggests that the RBX1-UBE2M complex neddylates specific target proteins, such as CUL1, CUL2, CUL3 and CUL4. Involved in cell proliferation

UBE2M Antibody (C-term) Blocking Peptide - Related products

AP1068a: UBE2M Antibody (N-term)

AP1068b: UBE2M Antibody (C-term)

AP2169a: UBE2M Antibody (N-term K11)

AP2169b: UBE2M Antibody (Center)

RI15581: UBE2M predesign siRNA

LY11934a: UBE2M Over-expression Lysate

BP1068a: UBE2M Antibody (N-term) Blocking Peptide

BP1068b: UBE2M Antibody (C-term) Blocking Peptide

BP2169a: UBE2M Antibody (N-term K11) Blocking Peptide

BP2169b: UBE2M Antibody (Center) Blocking Peptide

AT4440a: UBE2M Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is linked with a ubiquitin-like protein, NEDD8, which can be conjugated to cellular proteins, such as Cdc53/culin.

REFERENCES

Gong, L., et al., J. Biol. Chem. 274(17):12036-12042 (1999).Osaka, F., et al., Genes Dev. 12(15):2263-2268 (1998).